Champions Oncology is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Champions Oncology is a publicly traded company on using the ticker symbol CSBR.
Detailed information on company financials and operating reports can be found here:
: CSBR
Note: Champions Oncology's revenues are gauged from an analysis of company filings.
Investor Activity
Champions Oncology has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
March 25, 2015
11
100%
$14 MM
Complete list of funding rounds and total amounts in the Company Report
Market Share of Champions Oncology's Largest Competitors
A competitive analysis shows these companies are in the same general field as Champions Oncology, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Champions Oncology.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Champions Oncology's Fastest Growing Competitors
These companies are in the same general field as Champions Oncology and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.